In a recent webinar, industry luminaries including Harpreet Gill from ICON plc, Jane Twitchen from Biogen, Angela May from...

A significant shift towards prioritizing clinical trial patient engagement (PE) and patient experience data (PXD) is palpable in clinical...

Contract Research Organizations (CROs) and vendors stand as pillars in clinical trials, with sponsors thoroughly building Key Performance Indicators...

Integrating real world data into clinical trials is an emerging frontier, offering a transformative approach to clinical trial designs,...

In a recent panel discussion, leading experts from the clinical trials industry, including Craig Lipset with the Decentralized Trials...

Psychedelic therapy is a rapidly growing field with the potential to revolutionize the treatment of mental health disorders. In...

Decentralized clinical trials are at a pivotal juncture, shaped by technological advancements and evolving regulatory landscapes. While traditional clinical...

As the clinical trials industry embraces change, Decentralized Clinical Trials (DCTs) are emerging as the next significant evolution. Marrying...

Compassionate use, also known as expanded access, is a critical pathway for patients with life-threatening conditions to access investigational...

In today’s world, where data drives many decisions, the biopharmaceutical industry is no exception. Integrating data science into clinical...